Cryo-Cell International Inc (CCEL) stock
CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30
$4.85−0.55 (-10.19%)
Close on Nov 13, 2026Market cap $39.10MP/E –Yield –
Cryo-Cell International total assets
Total assets on the balance sheet at the end of each period.
Cryo-Cell International's total assets was $62.30M at Aug 31, 2026. For fiscal 2025 it was $61.73M, down 4.6% from the year before. Over ten years it grew 12.2% a year on average. The highest annual figure on record is $64.89M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $61.73M | -4.6% |
| FY2024 | Nov 30, 2024 | $64.68M | 0.0% |
| FY2023 | Nov 30, 2023 | $64.68M | -0.3% |
| FY2022 | Nov 30, 2022 | $64.89M | +7.0% |
| FY2021 | Nov 30, 2021 | $60.66M | +31.3% |
| FY2020 | Nov 30, 2020 | $46.20M | +7.7% |
| FY2019 | Nov 30, 2019 | $42.89M | 0.0% |
| FY2018 | Nov 30, 2018 | $42.89M | +79.4% |
| FY2017 | Nov 30, 2017 | $23.91M | +22.4% |
| FY2016 | Nov 30, 2016 | $19.54M | +0.2% |
| FY2015 | Nov 30, 2015 | $19.50M | +91.0% |
| FY2014 | Nov 30, 2014 | $10.21M | -11.2% |
| FY2013 | Nov 30, 2013 | $11.50M | -6.7% |
| FY2012 | Nov 30, 2012 | $12.33M | -36.7% |
| FY2011 | Nov 30, 2011 | $19.47M | +7.6% |
| FY2010 | Nov 30, 2010 | $18.09M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Aug 31, 2026 | $62.30M | -1.4% |
| Q2 FY2026CQ2 2026 | May 31, 2026 | $60.71M | -5.8% |
| Q1 FY2026CQ1 2026 | Feb 28, 2026 | $60.88M | -5.4% |
| Q4 FY2025CQ4 2025 | Nov 30, 2025 | $61.73M | -4.6% |
| Q3 FY2025CQ3 2025 | Aug 31, 2025 | $63.17M | +0.4% |
| Q2 FY2025CQ2 2025 | May 31, 2025 | $64.44M | +3.0% |
| Q1 FY2025CQ1 2025 | Feb 28, 2025 | $64.38M | +4.3% |
| Q4 FY2024CQ4 2024 | Nov 30, 2024 | $64.68M | 0.0% |
| Q3 FY2024CQ3 2024 | Aug 31, 2024 | $62.93M | -9.8% |
| Q2 FY2024CQ2 2024 | May 31, 2024 | $62.57M | -9.0% |
| Q1 FY2024CQ1 2024 | Feb 29, 2024 | $61.71M | -6.7% |
| Q4 FY2023CQ4 2023 | Nov 30, 2023 | $64.68M | -0.3% |
| Q3 FY2023CQ3 2023 | Aug 31, 2023 | $69.80M | +4.5% |
| Q2 FY2023CQ2 2023 | May 31, 2023 | $68.76M | +24.1% |
| Q1 FY2023CQ1 2023 | Feb 28, 2023 | $66.13M | +20.7% |
| Q4 FY2022CQ4 2022 | Nov 30, 2022 | $64.89M | +7.0% |
| Q3 FY2022CQ3 2022 | Aug 31, 2022 | $66.77M | +12.4% |
| Q2 FY2022CQ2 2022 | May 31, 2022 | $55.39M | -5.0% |
| Q1 FY2022CQ1 2022 | Feb 28, 2022 | $54.81M | -47.9% |
| Q4 FY2021CQ4 2021 | Nov 30, 2021 | $60.66M | +31.3% |
| Q3 FY2021CQ3 2021 | Aug 31, 2021 | $59.42M | +33.7% |
| Q2 FY2021CQ2 2021 | May 31, 2021 | $58.32M | +30.1% |
| Q1 FY2021CQ1 2021 | Feb 28, 2021 | $105.26M | +135.3% |
| Q4 FY2020CQ4 2020 | Nov 30, 2020 | $46.20M | +7.7% |
| Q3 FY2020CQ3 2020 | Aug 31, 2020 | $44.44M | +6.2% |
| Q2 FY2020CQ2 2020 | May 31, 2020 | $44.84M | +9.7% |
| Q1 FY2020CQ1 2020 | Feb 29, 2020 | $44.73M | +3.2% |
| Q4 FY2019CQ4 2019 | Nov 30, 2019 | $42.89M | 0.0% |
| Q3 FY2019CQ3 2019 | Aug 31, 2019 | $41.83M | -1.9% |
| Q2 FY2019CQ2 2019 | May 31, 2019 | $40.89M | +84.0% |
| Q1 FY2019CQ1 2019 | Feb 28, 2019 | $43.34M | +97.8% |
| Q4 FY2018CQ4 2018 | Nov 30, 2018 | $42.89M | +79.4% |
| Q3 FY2018CQ3 2018 | Aug 31, 2018 | $42.65M | +100.1% |
| Q2 FY2018CQ2 2018 | May 31, 2018 | $22.22M | +5.6% |
| Q1 FY2018CQ1 2018 | Feb 28, 2018 | $21.91M | +10.9% |
| Q4 FY2017CQ4 2017 | Nov 30, 2017 | $23.91M | +22.4% |
| Q3 FY2017CQ3 2017 | Aug 31, 2017 | $21.32M | – |
| Q2 FY2017CQ2 2017 | May 31, 2017 | $21.04M | – |
| Q1 FY2017CQ1 2017 | Feb 28, 2017 | $19.75M | – |
| Q4 FY2016CQ4 2016 | Nov 30, 2016 | $19.54M | – |
See a number that looks wrong?